Next Century Growth Investors’s Vertex Pharmaceuticals VRTX Stock Holding History

Next Century Growth Investors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,740	Closed	-$3.13M	–	149
2024 Q3	$3.13M	Sell	6,740 -957	-12%	-$460K	0.25%	97
2024 Q2	$3.61M	Sell	7,697 -2,225	-22%	-$966K	0.3%	86
2024 Q1	$4.15M	Buy	9,922 +3,735	+60%	+$1.58M	0.36%	82
2023 Q4	$2.52M	Sell	6,187 -6,501	-51%	-$2.4M	0.24%	92
2023 Q3	$4.41M	Buy	12,688 +2,779	+28%	+$972K	0.48%	54
2023 Q2	$3.49M	Hold	9,909	–	–	0.34%	73
2023 Q1	$3.12M	Sell	9,909 -229	-2%	-$68.7K	0.34%	67
2022 Q4	$2.93M	Buy	+10,138	New	+$3.09M	0.35%	71
2020 Q4	–	Sell	-8,144	Closed	-$2.22M	–	140
2020 Q3	$2.22M	Sell	8,144 -1,043	-11%	-$288K	0.23%	103
2020 Q2	$2.67M	Hold	9,187	–	–	0.3%	92
2020 Q1	$2.19M	Hold	9,187	–	–	0.35%	80
2019 Q4	$2.01M	Sell	9,187 -9,811	-52%	-$1.99M	0.26%	99
2019 Q3	$3.22M	Hold	18,998	–	–	0.52%	63
2019 Q2	$3.48M	Buy	18,998 +1,974	+12%	+$345K	0.43%	73
2019 Q1	$3.13M	Hold	17,024	–	–	0.42%	83
2018 Q4	$2.82M	Buy	17,024 +6,110	+56%	+$1.06M	0.4%	87
2018 Q3	$2.1M	Buy	+10,914	New	+$1.94M	0.24%	113

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Next Century Growth Investors's VRTX Position: Q4 2024 in Review

Next Century Growth Investors sold out of Vertex Pharmaceuticals (VRTX) in Q4 2024, closing a stake of 6,740 shares — an estimated $3.13M sold.

Next Century Growth Investors first reported a position in VRTX in Q3 2018 and held it in 17 quarters. The position peaked at $4.41M in Q3 2023. 1,558 funds tracked by Wall St. Rank hold VRTX as of Q4 2024.

Next Century Growth Investors reported no remaining Vertex Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Next Century Growth Investors sold 6,740 Vertex Pharmaceuticals shares in Q4 2024, an estimated $3.13M.
Next Century Growth Investors first reported a position in Vertex Pharmaceuticals in Q3 2018 and held it in 17 quarters.
Next Century Growth Investors's Vertex Pharmaceuticals position peaked at $4.41M in Q3 2023.
1,558 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2024.

Based on Next Century Growth Investors's 13F filing for Q4 2024, filed 13 Feb 2025.